Financial Results
Security Name
 
Natco Pharma Ltd (524816)

Financial YearQuarterTypeStatusFiling_Date_TimeRevised_Date_TimeRevision_ReasonStandalone XBRLConsolidate XBRLStandalone Trend
2024-2025Consolidated-Dec-24QuarterNew12-02-2025 16:47:24- View
2024-2025Standalone-Dec-24QuarterNew12-02-2025 16:45:35- View
2024-2025Standalone-Sep-24QuarterNew12-11-2024 15:47:09- View
2024-2025Consolidated-Sep-24QuarterNew12-11-2024 15:45:33- View
2024-2025Consolidated-Jun-24QuarterNew13-08-2024 13:05:06- View
2024-2025Standalone-Jun-24QuarterNew13-08-2024 13:04:11- View
2023-2024Consolidated-Mar-24YearNew27-05-2024 18:32:57- View
2023-2024Consolidated-Mar-24QuarterNew27-05-2024 18:32:13- View
2023-2024Standalone-Mar-24YearNew27-05-2024 18:31:03- View
2023-2024Standalone-Mar-24QuarterNew27-05-2024 18:30:16- View
2023-2024Consolidated-Dec-23QuarterNew15-02-2024 10:52:31- View
2023-2024Standalone-Dec-23QuarterNew15-02-2024 10:51:39- View
2023-2024Consolidated-Sep-23QuarterNew15-11-2023 17:18:02- View
2023-2024Standalone-Sep-23QuarterNew15-11-2023 17:02:08- View
2023-2024Standalone-Jun-23QuarterNew09-08-2023 17:09:48- View
 <<Prev    Next >>  


Site optimized for IE9 & above. | Disclaimer | Website Policies | Privacy Policy | Sitemap Copyright © BSE Ltd. All Rights Reserved.
21 Apr 25 | 11:37 (IST)
(20H)